Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Arm PharmacoKinetic/PharmacoDynamic and Safety Study of Eryaspase (GRASPA®) for Patients With Hypersensitivity to PEG-Asparaginase, Diagnosed With Ph(-) Acute Lymphoblastic Leukemia

NCT03267030 is registered in ClinicalTrials.gov with Birgitte Klug Albertsen as lead sponsor.

NCT NCT03267030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03267030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Arm PharmacoKinetic/PharmacoDynamic and Safety Study of Eryaspase (GRASPA®) for Patients With Hypersensitivity to PEG-Asparaginase, Diagnosed With Ph(-) Acute Lymphoblastic Leukemia
Lead sponsor
Birgitte Klug Albertsen
Phase
Phase 2
Overall status
Completed
Start date
August 23, 2017
Completion date
October 22, 2020
Enrollment
55 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia